Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 265

1.

Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.

Frassanito MA, Desantis V, Di Marzo L, Craparotta I, Beltrame L, Marchini S, Annese T, Visino F, Arciuli M, Saltarella I, Lamanuzzi A, Solimando AG, Nico B, De Angelis M, Racanelli V, Mariggiò MA, Chiacchio R, Pizzuti M, Gallone A, Fumarulo R, D'Incalci M, Vacca A.

J Pathol. 2018 Oct 25. doi: 10.1002/path.5187. [Epub ahead of print]

PMID:
30357841
2.

Bcl6/p53 expression, macrophages/mast cells infiltration and microvascular density in invasive breast carcinoma.

Tamma R, Ruggieri S, Annese T, Simone G, Mangia A, Rega S, Zito FA, Nico B, Ribatti D.

Oncotarget. 2018 Apr 27;9(32):22727-22740. doi: 10.18632/oncotarget.25220. eCollection 2018 Apr 27.

3.

VEGFA and VEGFR2 RNAscope determination in gastric cancer.

Tamma R, Annese T, Ruggieri S, Marzullo A, Nico B, Ribatti D.

J Mol Histol. 2018 May 14. doi: 10.1007/s10735-018-9777-0. [Epub ahead of print]

PMID:
29761299
4.

Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma.

Lamanuzzi A, Saltarella I, Desantis V, Frassanito MA, Leone P, Racanelli V, Nico B, Ribatti D, Ditonno P, Prete M, Solimando AG, Dammacco F, Vacca A, Ria R.

Oncotarget. 2018 Apr 17;9(29):20563-20577. doi: 10.18632/oncotarget.25003. eCollection 2018 Apr 17.

5.

Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma.

Desantis V, Frassanito MA, Tamma R, Saltarella I, Di Marzo L, Lamanuzzi A, Solimando AG, Ruggieri S, Annese T, Nico B, Vacca A, Ribatti D.

Ann Hematol. 2018 Jul;97(7):1251-1258. doi: 10.1007/s00277-018-3293-x. Epub 2018 Mar 28.

PMID:
29589107
6.

Dystrophin 71 and α1syntrophin in morpho-functional plasticity of rat supraoptic nuclei: Effect of saline surcharge and reversibly normal hydration.

Sifi M, Benabdesselam R, Souttou S, Annese T, Rendon A, Nico B, Dorbani-Mamine L.

Acta Histochem. 2018 Apr;120(3):187-195. doi: 10.1016/j.acthis.2018.01.004. Epub 2018 Feb 1.

PMID:
29395317
7.

Reduced myofilament component in primary Sjögren's syndrome salivary gland myoepithelial cells.

Sisto M, Lorusso L, Ingravallo G, Tamma R, Nico B, Ribatti D, Ruggieri S, Lisi S.

J Mol Histol. 2018 Apr;49(2):111-121. doi: 10.1007/s10735-017-9751-2. Epub 2018 Jan 4.

PMID:
29302763
8.

Spatial distribution of mast cells and macrophages around tumor glands in human breast ductal carcinoma.

Tamma R, Guidolin D, Annese T, Tortorella C, Ruggieri S, Rega S, Zito FA, Nico B, Ribatti D.

Exp Cell Res. 2017 Oct 1;359(1):179-184. doi: 10.1016/j.yexcr.2017.07.033. Epub 2017 Jul 27.

PMID:
28756894
9.

Abnormal distribution of AQP4 in minor salivary glands of primary Sjögren's syndrome patients.

Sisto M, Lorusso L, Ingravallo G, Nico B, Ribatti D, Ruggieri S, Lofrumento DD, Lisi S.

Autoimmunity. 2017 Jun;50(4):202-210. doi: 10.1080/08916934.2017.1341495. Epub 2017 Jun 24.

PMID:
28648105
10.

Mast cells in breast cancer angiogenesis.

Cimpean AM, Tamma R, Ruggieri S, Nico B, Toma A, Ribatti D.

Crit Rev Oncol Hematol. 2017 Jul;115:23-26. doi: 10.1016/j.critrevonc.2017.04.009. Epub 2017 Apr 27. Review.

PMID:
28602166
11.

Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma.

Ruggieri S, Tamma R, Resta N, Albano F, Coccaro N, Loconte D, Annese T, Errede M, Specchia G, Senetta R, Cassoni P, Ribatti D, Nico B.

Oncotarget. 2017 May 9;8(19):31254-31269. doi: 10.18632/oncotarget.16115.

12.

Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer.

Ribatti D, Nico B, Ruggieri S, Tamma R, Simone G, Mangia A.

Transl Oncol. 2016 Oct;9(5):453-457. doi: 10.1016/j.tranon.2016.07.002. Review.

13.

Microenvironment drug resistance in multiple myeloma: emerging new players.

Di Marzo L, Desantis V, Solimando AG, Ruggieri S, Annese T, Nico B, Fumarulo R, Vacca A, Frassanito MA.

Oncotarget. 2016 Sep 13;7(37):60698-60711. doi: 10.18632/oncotarget.10849. Review.

14.

Corrigendum to "Isolation and characterization of neural stem cells from dystrophic mdx mouse" [Exp. Cell Res. 343(2016)190-207].

Annese T, Corsi P, Ruggieri S, Tamma R, Marinaccio C, Picocci S, Errede M, Specchia G, DeLuca A, Frassanito MA, Desantis V, Vacca A, Ribatti D, Nico B.

Exp Cell Res. 2016 Aug 15;346(2):255. doi: 10.1016/j.yexcr.2016.07.016. Epub 2016 Jul 21. No abstract available.

PMID:
27450895
15.

Isolation and characterization of neural stem cells from dystrophic mdx mouse.

Annese T, Corsi P, Ruggieri S, Tamma R, Marinaccio C, Picocci S, Errede M, Specchia G, De Luca A, Frassanito MA, Desantis V, Vacca A, Ribatti D, Nico B.

Exp Cell Res. 2016 May 1;343(2):190-207. doi: 10.1016/j.yexcr.2016.03.019. Epub 2016 Mar 22.

PMID:
27015747
16.

Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of duchenne muscular dystrophy: A comparison with the gold standard, α-methyl prednisolone.

Capogrosso RF, Cozzoli A, Mantuano P, Camerino GM, Massari AM, Sblendorio VT, De Bellis M, Tamma R, Giustino A, Nico B, Montagnani M, De Luca A.

Pharmacol Res. 2016 Apr;106:101-113. doi: 10.1016/j.phrs.2016.02.016. Epub 2016 Feb 27.

PMID:
26930420
17.

Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients.

Lamanuzzi A, Saltarella I, Ferrucci A, Ria R, Ruggieri S, Racanelli V, Rao L, Annese T, Nico B, Vacca A, Ribatti D.

Oncotarget. 2016 Mar 22;7(12):14510-21. doi: 10.18632/oncotarget.7587.

18.

Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients.

Frassanito MA, De Veirman K, Desantis V, Di Marzo L, Vergara D, Ruggieri S, Annese T, Nico B, Menu E, Catacchio I, Ria R, Racanelli V, Maffia M, Angelucci E, Derudas D, Fumarulo R, Dammacco F, Ribatti D, Vanderkerken K, Vacca A.

Leukemia. 2016 Mar;30(3):640-8. doi: 10.1038/leu.2015.289. Epub 2015 Oct 21.

PMID:
26487273
19.

Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease.

Giacomini A, Ackermann M, Belleri M, Coltrini D, Nico B, Ribatti D, Konerding MA, Presta M, Righi M.

Angiogenesis. 2015 Oct;18(4):499-510. doi: 10.1007/s10456-015-9481-6. Epub 2015 Aug 27.

PMID:
26310512
20.

T cells, mast cells and microvascular density in diffuse large B cell lymphoma.

Marinaccio C, Ingravallo G, Gaudio F, Perrone T, Ruggieri S, Opinto G, Nico B, Maiorano E, Specchia G, Ribatti D.

Clin Exp Med. 2016 Aug;16(3):301-6. doi: 10.1007/s10238-015-0354-5. Epub 2015 May 10.

PMID:
25957593
21.

Multiple myeloma as a model for the role of bone marrow niches in the control of angiogenesis.

Ribatti D, Nico B, Vacca A.

Int Rev Cell Mol Biol. 2015;314:259-82. doi: 10.1016/bs.ircmb.2014.10.004. Epub 2014 Nov 18. Review.

PMID:
25619720
22.

The development of the vascular system: a historical overview.

Ribatti D, Nico B, Crivellato E.

Methods Mol Biol. 2015;1214:1-14. doi: 10.1007/978-1-4939-1462-3_1. Review.

PMID:
25468595
23.

Osteoblast regulation via ligand-activated nuclear trafficking of the oxytocin receptor.

Di Benedetto A, Sun L, Zambonin CG, Tamma R, Nico B, Calvano CD, Colaianni G, Ji Y, Mori G, Grano M, Lu P, Colucci S, Yuen T, New MI, Zallone A, Zaidi M.

Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):16502-7. doi: 10.1073/pnas.1419349111. Epub 2014 Nov 5.

24.

Microvascular density, CD68 and tryptase expression in human diffuse large B-cell lymphoma.

Marinaccio C, Ingravallo G, Gaudio F, Perrone T, Nico B, Maoirano E, Specchia G, Ribatti D.

Leuk Res. 2014 Nov;38(11):1374-7. doi: 10.1016/j.leukres.2014.09.007. Epub 2014 Sep 22.

PMID:
25293515
25.

Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme.

Ruggieri S, Tamma R, Marzullo A, Annese T, Marinaccio C, Errede M, Susca FC, Senetta R, Cassoni P, Vacca A, Albano F, Saracino C, Notarangelo A, Specchia G, Ribatti D, Nico B.

Cancer Lett. 2014 Oct 10;353(1):41-51. doi: 10.1016/j.canlet.2014.06.017. Epub 2014 Jul 17.

26.

Insights in Hodgkin Lymphoma angiogenesis.

Marinaccio C, Nico B, Maiorano E, Specchia G, Ribatti D.

Leuk Res. 2014 Aug;38(8):857-61. doi: 10.1016/j.leukres.2014.05.023. Epub 2014 Jun 4. Review.

PMID:
24957412
27.

Calbindin-D28K immunoreactivity in the human cerebellar cortex.

Flace P, Lorusso L, Laiso G, Rizzi A, Cagiano R, Nico B, Ribatti D, Ambrosi G, Benagiano V.

Anat Rec (Hoboken). 2014 Jul;297(7):1306-15. doi: 10.1002/ar.22921. Epub 2014 Apr 10.

28.

Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease.

Ferretta A, Gaballo A, Tanzarella P, Piccoli C, Capitanio N, Nico B, Annese T, Di Paola M, Dell'aquila C, De Mari M, Ferranini E, Bonifati V, Pacelli C, Cocco T.

Biochim Biophys Acta. 2014 Jul;1842(7):902-15. doi: 10.1016/j.bbadis.2014.02.010. Epub 2014 Feb 25.

29.

HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target.

Ria R, Catacchio I, Berardi S, De Luisi A, Caivano A, Piccoli C, Ruggieri V, Frassanito MA, Ribatti D, Nico B, Annese T, Ruggieri S, Guarini A, Minoia C, Ditonno P, Angelucci E, Derudas D, Moschetta M, Dammacco F, Vacca A.

Clin Cancer Res. 2014 Feb 15;20(4):847-58. doi: 10.1158/1078-0432.CCR-13-1950. Epub 2013 Dec 2.

30.

Aquaporins in cancer.

Ribatti D, Ranieri G, Annese T, Nico B.

Biochim Biophys Acta. 2014 May;1840(5):1550-3. doi: 10.1016/j.bbagen.2013.09.025. Epub 2013 Sep 21. Review.

PMID:
24064112
31.

Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies.

Frassanito MA, Rao L, Moschetta M, Ria R, Di Marzo L, De Luisi A, Racanelli V, Catacchio I, Berardi S, Basile A, Menu E, Ruggieri S, Nico B, Ribatti D, Fumarulo R, Dammacco F, Vanderkerken K, Vacca A.

Leukemia. 2014 Apr;28(4):904-16. doi: 10.1038/leu.2013.254. Epub 2013 Sep 2.

PMID:
23995611
32.

Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy.

Belleri M, Ronca R, Coltrini D, Nico B, Ribatti D, Poliani PL, Giacomini A, Alessi P, Marchesini S, Santos MB, Bongarzone ER, Presta M.

Brain. 2013 Sep;136(Pt 9):2859-75. doi: 10.1093/brain/awt215.

33.

Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma.

Moschetta M, Basile A, Ferrucci A, Frassanito MA, Rao L, Ria R, Solimando AG, Giuliani N, Boccarelli A, Fumarola F, Coluccia M, Rossini B, Ruggieri S, Nico B, Maiorano E, Ribatti D, Roccaro AM, Vacca A.

Clin Cancer Res. 2013 Aug 15;19(16):4371-82. doi: 10.1158/1078-0432.CCR-13-0039. Epub 2013 Jun 26.

34.

Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma.

Di Paolo D, Pastorino F, Zuccari G, Caffa I, Loi M, Marimpietri D, Brignole C, Perri P, Cilli M, Nico B, Ribatti D, Pistoia V, Ponzoni M, Pagnan G.

J Control Release. 2013 Sep 28;170(3):445-51. doi: 10.1016/j.jconrel.2013.06.015. Epub 2013 Jun 19.

PMID:
23792118
35.

Effects of prednisolone on the dystrophin-associated proteins in the blood-brain barrier and skeletal muscle of dystrophic mdx mice.

Tamma R, Annese T, Capogrosso RF, Cozzoli A, Benagiano V, Sblendorio V, Ruggieri S, Crivellato E, Specchia G, Ribatti D, De Luca A, Nico B.

Lab Invest. 2013 May;93(5):592-610. doi: 10.1038/labinvest.2013.46. Epub 2013 Mar 25.

36.

The role of angiogenesis in human non-Hodgkin lymphomas.

Ribatti D, Nico B, Ranieri G, Specchia G, Vacca A.

Neoplasia. 2013 Mar;15(3):231-8. Review.

37.
38.

An active mitochondrial biogenesis occurs during dendritic cell differentiation.

Zaccagnino P, Saltarella M, Maiorano S, Gaballo A, Santoro G, Nico B, Lorusso M, Del Prete A.

Int J Biochem Cell Biol. 2012 Nov;44(11):1962-9. doi: 10.1016/j.biocel.2012.07.024. Epub 2012 Jul 31.

PMID:
22871569
39.

B16-F10 melanoma cells contribute to the new formation of blood vessels in the chick embryo chorioallantoic membrane through vasculogenic mimicry.

Ribatti D, Nico B, Cimpean AM, Raica M, Crivellato E, Ruggieri S, Vacca A.

Clin Exp Med. 2013 May;13(2):143-7. doi: 10.1007/s10238-012-0183-8. Epub 2012 Apr 19.

PMID:
22527563
40.

The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an antiangiogenic multitarget fibroblast growth factor-2 antagonist.

Liekens S, Bronckaers A, Belleri M, Bugatti A, Sienaert R, Ribatti D, Nico B, Gigante A, Casanova E, Opdenakker G, Pérez-Pérez MJ, Balzarini J, Presta M.

Mol Cancer Ther. 2012 Apr;11(4):817-29. doi: 10.1158/1535-7163.MCT-11-0738. Epub 2012 Feb 1.

41.

Morphofunctional aspects of the blood-brain barrier.

Nico B, Ribatti D.

Curr Drug Metab. 2012 Jan;13(1):50-60. Review.

PMID:
22292807
42.

Aquaporin-4 expression in primary human central nervous system lymphomas correlates with tumour cell proliferation and phenotypic heterogeneity of the vessel wall.

Nico B, Annese T, Tamma R, Longo V, Ruggieri S, Senetta R, Cassoni P, Specchia G, Vacca A, Ribatti D.

Eur J Cancer. 2012 Mar;48(5):772-81. doi: 10.1016/j.ejca.2011.10.022. Epub 2011 Nov 17.

PMID:
22100902
43.

VAMP-2, SNAP-25A/B and syntaxin-1 in glutamatergic and GABAergic synapses of the rat cerebellar cortex.

Benagiano V, Lorusso L, Flace P, Girolamo F, Rizzi A, Bosco L, Cagiano R, Nico B, Ribatti D, Ambrosi G.

BMC Neurosci. 2011 Nov 17;12:118. doi: 10.1186/1471-2202-12-118.

44.

Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets.

Berardi S, Caivano A, Ria R, Nico B, Savino R, Terracciano R, De Tullio G, Ferrucci A, De Luisi A, Moschetta M, Mangialardi G, Catacchio I, Basile A, Guarini A, Zito A, Ditonno P, Musto P, Dammacco F, Ribatti D, Vacca A.

Oncogene. 2012 May 3;31(18):2258-69. doi: 10.1038/onc.2011.412. Epub 2011 Oct 3.

PMID:
21963844
45.

In vitro and in vivo pro-angiogenic effects of thymosin-β4-derived peptides.

Dettin M, Ghezzo F, Conconi MT, Urbani L, D'Auria G, Falcigno L, Guidolin D, Nico B, Ribatti D, Di Bello C, Parnigotto PP.

Cell Immunol. 2011;271(2):299-307. doi: 10.1016/j.cellimm.2011.07.008. Epub 2011 Jul 29.

PMID:
21872226
46.

Role of aquaporins in cell migration and edema formation in human brain tumors.

Nico B, Ribatti D.

Exp Cell Res. 2011 Oct 15;317(17):2391-6. doi: 10.1016/j.yexcr.2011.07.006. Epub 2011 Jul 20. Review.

PMID:
21784068
47.

The history of the controversial relationship between mast cells and basophils.

Crivellato E, Nico B, Ribatti D.

Immunol Lett. 2011 Dec 30;141(1):10-7. doi: 10.1016/j.imlet.2011.06.008. Epub 2011 Jul 2. Review.

PMID:
21756940
48.

The role of pericytes in angiogenesis.

Ribatti D, Nico B, Crivellato E.

Int J Dev Biol. 2011;55(3):261-8. doi: 10.1387/ijdb.103167dr. Review.

49.

Tryptase-positive mast cells and CD8-positive T cells in human endometrial cancer.

Ribatti D, Nico B, Finato N, Crivellato E.

Pathol Int. 2011 Jul;61(7):442-4. doi: 10.1111/j.1440-1827.2011.02680.x.

PMID:
21707849
50.

Enalapril treatment discloses an early role of angiotensin II in inflammation- and oxidative stress-related muscle damage in dystrophic mdx mice.

Cozzoli A, Nico B, Sblendorio VT, Capogrosso RF, Dinardo MM, Longo V, Gagliardi S, Montagnani M, De Luca A.

Pharmacol Res. 2011 Nov;64(5):482-92. doi: 10.1016/j.phrs.2011.06.002. Epub 2011 Jun 13.

Supplemental Content

Support Center